 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Protein Interaction Study Bolsters Case for HER3 as Major Player in Cancer Development
September 14, 2012
Protein Interaction Study Bolsters Case for HER3 as Major Player in Cancer Development
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - UK's NICE Backs Iressa Coverage at Fixed Price; NHS Pays for Genetic Testing
June 2, 2010 / Pharmacogenomics Reporter - KineMed, MedImmune Studying Role of Protein Dynamics in Neurodegenerative Diseases
May 21, 2013 / GenomeWeb Daily News - GMU Phosphoproteomic Studies Offer Potential Clinical Insights on Breast, Colorectal Cancers
October 12, 2012 / ProteoMonitor - 20/20 GeneSystems Developing mTOR Pathway Test to Predict Herceptin Response in HER2-Positive Patients
September 19, 2012 / Pharmacogenomics Reporter